Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Tarsus Pharmaceuticals (TARS) Inventory Average (2023 - 2025)

Historic Inventory Average for Tarsus Pharmaceuticals (TARS) over the last 3 years, with Q3 2025 value amounting to $3.9 million.

  • Tarsus Pharmaceuticals' Inventory Average rose 5292.6% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 5292.6%. This contributed to the annual value of $2.9 million for FY2024, which is N/A changed from last year.
  • Tarsus Pharmaceuticals' Inventory Average amounted to $3.9 million in Q3 2025, which was up 5292.6% from $3.3 million recorded in Q2 2025.
  • Over the past 5 years, Tarsus Pharmaceuticals' Inventory Average peaked at $3.9 million during Q3 2025, and registered a low of $1.6 million during Q4 2023.
  • In the last 3 years, Tarsus Pharmaceuticals' Inventory Average had a median value of $2.9 million in 2024 and averaged $2.9 million.
  • Its Inventory Average has fluctuated over the past 5 years, first surged by 7508.01% in 2024, then crashed by 2545.15% in 2025.
  • Tarsus Pharmaceuticals' Inventory Average (Quarter) stood at $1.6 million in 2023, then surged by 75.08% to $2.7 million in 2024, then surged by 41.04% to $3.9 million in 2025.
  • Its Inventory Average stands at $3.9 million for Q3 2025, versus $3.3 million for Q2 2025 and $2.7 million for Q1 2025.